HPV Testing & Pap Test Market Value to Expand $55.92 Billion by 2025 | Key Vendors - BD, Roche, Abbott, Qiagen

Global HPV Testing & Pap Test Market Synopsis:

The exclusive research report on the Global HPV Testing & Pap Test Market 2021-2025 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global HPV Testing & Pap Test Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

The Global HPV Testing & Pap Test Market has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, HPV Testing & Pap Test market size to maintain the average annual growth rate of 0.099088855885 from $15.84 Billion in 2015 to $25.405 Billion in 2019, market analysts believe that in the next few years, HPV Testing & Pap Test market size will be further expanded, we expect that by 2025, The market size of the HPV Testing & Pap Test will reach $55.92 Billion.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/284022 .

Some of the most important key factors driving the growth of the Global HPV Testing & Pap Test Market are increasing incidence rate of cervical and vaginal cancer. In addition, the causative agent of cervical cancer is a sexually-transmissible genital virus, the HPV. In cases of chronic HPV infections, the formed pre-malignant lesions or abnormal cell growths in the reproductive tract give rise to a more progressive and malignant form of cervical cancer. The HPV test and Pap test help in the screening and early detection of cervical cancer, which facilitates timely intervention at an early stage in women.

Regionally, North America was the largest regional market in terms of revenue due to the increased cases of cervical cancer and the growing awareness amongst women due to the various government initiatives and research studies that were undertaken in this direction. APAC is expected to grow at a rapid rate over the forecast period owing to the increasing burden of communicable diseases in developing economies such as India. The increasing number of government awareness programs that promote the benefits of early cancer screening is further expected to propel the market growth in the coming years.

Top Major Key Players in the Global HPV Testing & Pap Test Market:

1 Abbott Laboratories

2 Qiagen NV

3 Roche Diagnostics

4 Hologic, Inc

5 Becton, Dickinson And Company

6 Quest Diagnostics

7 Onco Health Corporation

8 Seegene, Inc

9 Femasys Inc

10 Arbor Vita Corporation and More…………….

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global HPV Testing & Pap Test Market Report 2021” @ https://www.businessindustryreports.com/buy-now/284022/single .

Product Type Segmentation

1 Hpv Testing

2 Follow-Up Hpv Testing

3 Co-Testing

4 Primary Hpv Testing

5 Pap Test

Industry Segmentation

1 Laboratories

2 Hospitals

3 Physicians' Offices and Clinics

Global Medical Industry News:

Roche (March 08, 2021) - Roche provides update on Tecentriq US indication in prior-platinum treated metastatic bladder cancer - Roche today announced that the company is voluntarily withdrawing the US indication for Tecentriq (atezolizumab) in prior-platinum treated metastatic urothelial carcinoma (mUC, bladder cancer). This decision was made in consultation with the US Food and Drug Administration (FDA) as part of an industry-wide review of accelerated approvals with confirmatory trials that have not met their primary endpoint(s) and have yet to gain regular approvals. Roche will work with the FDA over the coming weeks to complete the withdrawal process. This decision does not affect other approved indications for Tecentriq. Roche is notifying healthcare professionals about this withdrawal. Patients being treated with Tecentriq for prior-platinum treated mUC should discuss their care with their healthcare provider.

“The Accelerated Approval Program allows people with difficult-to-treat cancers to receive certain new therapies earlier,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “While the withdrawal of Tecentriq for prior-platinum treated bladder cancer is disappointing, Tecentriq continues to demonstrate benefits across multiple cancer types and therefore remains a meaningful treatment option for many patients.”

The FDA's Accelerated Approval Program allows conditional approval of a medicine that fills an unmet medical need for a serious condition, with specific post marketing requirements (PMRs) to confirm the clinical benefit and convert to regular approval.

Tecentriq was granted accelerated approval in 2016 for the treatment of prior-platinum treated mUC based on the results from the IMvigor210 study (Cohort 2). Continued approval for this indication was contingent upon the results of IMvigor211, the original PMR for the prior-platinum treated mUC indication. This study did not meet its primary endpoint of overall survival in the PD-L1 high patient population. Subsequently, the FDA designated the IMvigor130 study as the PMR which will still continue until the final analysis. However, as the treatment landscape in prior-platinum (second-line) mUC has rapidly evolved with the emergence of new treatment options, Roche is voluntarily withdrawing this indication in recognition of the principles of the Accelerated Approval Program.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/284022 .

Major Points in Table of Contents:

Global HPV Testing & Pap Test Market Report 2021

1 HPV Testing & Pap Test Product Definition

2 Global HPV Testing & Pap Test Market Manufacturer Share and Market Overview

2.1 Global Manufacturer HPV Testing & Pap Test Shipments

2.2 Global Manufacturer HPV Testing & Pap Test Business Revenue

2.3 Global HPV Testing & Pap Test Market Overview

2.4 COVID-19 Impact on HPV Testing & Pap Test Industry

3 Manufacturer HPV Testing & Pap Test Business Introduction

3.1 Abbott Laboratories HPV Testing & Pap Test Business Introduction

3.2 Qiagen N.V. HPV Testing & Pap Test Business Introduction

3.3 Roche Diagnostics HPV Testing & Pap Test Business Introduction

3.4 Hologic, Inc. HPV Testing & Pap Test Business Introduction

3.5 Becton, Dickinson And Company HPV Testing & Pap Test Business Introduction

3.6 Quest Diagnostics HPV Testing & Pap Test Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that hold the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.